Emyria CEO Dr Michael Winlo recently had the opportunity to present at TSN’s ASX Gems Investment Conference.

As part of the presentation he shared the Company’s vision to scale our innovative clinical care model to meet underserved patient needs in mental health, including progress from our lead program evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder (PTSD).

Watch the replay: